Ticker
RLAYCompany Name
RELAY THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 601.72M | $ 220.34M | $ 0 | $ 0 | -36.62% |
3/31/2025 | $ 569.2M | $ 221.23M | $ 0 | $ 0 | -38.87% |
12/31/2024 | $ 635.71M | $ 270.15M | $ 0 | $ 0 | -42.5% |
9/30/2024 | $ 1.05B | $ 291.27M | $ 0 | $ 0 | -27.84% |
6/30/2024 | $ 962.67M | $ 81.84M | $ 0 | $ 0 | -8.5% |
3/31/2024 | $ 939.81M | $ 82.38M | $ 0 | $ 0 | -8.77% |
12/31/2023 | $ 1.39B | $ 34.75M | $ 0 | $ 0 | -2.51% |
9/30/2023 | $ 912.19M | $ 14M | $ 0 | $ 0 | -1.53% |
6/30/2023 | $ 1.36B | $ 290.41M | $ 0 | $ 0 | -21.29% |
3/31/2023 | $ 1.36B | $ 290.32M | $ 0 | $ 0 | -21.28% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for RELAY THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 4.29B ]
(=) Shareholder Yield [ 0% ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |